{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:41Z","timestamp":1792787981942,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Xuzhou Young Reserve Medical Talent Development Proiect","award":["XWRCSL20220113"],"award-info":[{"award-number":["XWRCSL20220113"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273111"],"award-info":[{"award-number":["82273111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"This study was supported by the Key Research & Development Plan (Social Development) of Jiangsu province","award":["BE2022714 to X.Z."],"award-info":[{"award-number":["BE2022714 to X.Z."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-02776-y","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:02:12Z","timestamp":1724112132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Ji","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"2776_CR1","first-page":"v1","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, et al. CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2015\u20132019. Neurooncology. 2022;24:v1\u201395.","journal-title":"Neurooncology"},{"issue":"7","key":"2776_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574\u201387.","journal-title":"JAMA"},{"key":"2776_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","volume":"499","author":"T Jiang","year":"2021","unstructured":"Jiang T, et al. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2021;499:60\u201372.","journal-title":"Cancer Lett"},{"issue":"4","key":"2776_CR4","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, et al. Management of glioblastoma: state of the art and future directions. Ca-a Cancer J Clin. 2020;70(4):299\u2013312.","journal-title":"Ca-a Cancer J Clin"},{"key":"2776_CR5","doi-asserted-by":"crossref","unstructured":"Fu MY et al. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Therapy, 2022. 7(1).","DOI":"10.1038\/s41392-022-01191-9"},{"issue":"3","key":"2776_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","volume":"122","author":"JB Huang","year":"2005","unstructured":"Huang JB, et al. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 2005;122(3):421\u201334.","journal-title":"Cell"},{"issue":"12","key":"2776_CR7","first-page":"2107","volume":"24","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1. Neurooncology. 2022;24(12):2107\u201320.","journal-title":"Neurooncology"},{"key":"2776_CR8","doi-asserted-by":"crossref","unstructured":"Zhao M et al. YAP promotes autophagy and progression of gliomas via upregulating HMGB1. J Experimental Clin Cancer Res, 2021. 40(1).","DOI":"10.1186\/s13046-021-01897-8"},{"key":"2776_CR9","doi-asserted-by":"crossref","unstructured":"Wang Y et al. beta-catenin-mediated YAP signaling promotes human glioma growth Journal of Experimental & Clinical Cancer Research, 2017. 36.","DOI":"10.1186\/s13046-017-0606-1"},{"issue":"2","key":"2776_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12031-017-1018-6","volume":"64","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, et al. YAP promotes Migration and Invasion of Human Glioma cells. J Mol Neurosci. 2018;64(2):262\u201372.","journal-title":"J Mol Neurosci"},{"issue":"27","key":"2776_CR11","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1038\/s41388-021-01878-3","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair. Oncogene. 2021;40(27):4580\u201391.","journal-title":"Oncogene"},{"key":"2776_CR12","doi-asserted-by":"crossref","unstructured":"Pobbati AV, Rubin BP. Protein-protein Interaction disruptors of the YAP\/TAZ-TEAD transcriptional complex. Molecules, 2020. 25(24).","DOI":"10.3390\/molecules25246001"},{"issue":"5","key":"2776_CR13","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-20-0018","volume":"27","author":"K Vigneswaran","year":"2021","unstructured":"Vigneswaran K, et al. YAP\/TAZ transcriptional coactivators create therapeutic vulnerability to Verteporfin in EGFR-mutant Glioblastoma. Clin Cancer Res. 2021;27(5):1553\u201369.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2776_CR14","first-page":"694","volume":"24","author":"AM Barrette","year":"2022","unstructured":"Barrette AM, et al. Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor Verteporfin in preclinical glioblastoma models. Neurooncology. 2022;24(5):694\u2013707.","journal-title":"Neurooncology"},{"issue":"4","key":"2776_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd.2015.21","volume":"15","author":"WA Banks","year":"2016","unstructured":"Banks WA. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discovery. 2016;15(4):275\u2013.","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"2776_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10717544.2022.2154409","volume":"30","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, et al. Recent advances in drug delivery systems for targeting brain tumors. Drug Delivery. 2023;30(1):1\u201318.","journal-title":"Drug Delivery"},{"key":"2776_CR17","doi-asserted-by":"crossref","unstructured":"Khare P et al. Lipid nanoparticle-mediated drug delivery to the brain. Adv Drug Deliv Rev, 2023. 197.","DOI":"10.1016\/j.addr.2023.114861"},{"issue":"23","key":"2776_CR18","doi-asserted-by":"publisher","first-page":"12883","DOI":"10.1039\/D1CS00559F","volume":"50","author":"N Singh","year":"2021","unstructured":"Singh N, et al. Nanoscale porous organic polymers for drug delivery and advanced cancer theranostics. Chem Soc Rev. 2021;50(23):12883\u201396.","journal-title":"Chem Soc Rev"},{"key":"2776_CR19","doi-asserted-by":"crossref","unstructured":"Zou Y et al. Brain co-delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy. Adv Mater, 2022. 34(33).","DOI":"10.1002\/adma.202203958"},{"key":"2776_CR20","doi-asserted-by":"crossref","unstructured":"Zou Y et al. Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine (vol 30, 1803717, 2018). Advanced Materials, 2023. 35(16).","DOI":"10.1002\/adma.202300776"},{"issue":"1","key":"2776_CR21","first-page":"100548","volume":"5","author":"M Tian","year":"2024","unstructured":"Tian M, Ma Z, Yang G-Z. Micro\/nanosystems for controllable drug delivery to the brain. Innov. 2024;5(1):100548.","journal-title":"Innov"},{"issue":"1","key":"2776_CR22","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.59717\/j.xinn-med.2023.100015","volume":"1","author":"H Lu","year":"2023","unstructured":"Lu H, Wang Y, Yu R. Immune cell membrane-coated nanoparticles for targeted myocardial ischemia\/reperfusion injury therapy. Innov Med. 2023;1(1):100015.","journal-title":"Innov Med"},{"key":"2776_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jconrel.2023.03.019","volume":"356","author":"YP Wang","year":"2023","unstructured":"Wang YP, et al. Charge-conversional click polyprodrug nanomedicine for targeted and synergistic cancer therapy. J Controlled Release. 2023;356:567\u201379.","journal-title":"J Controlled Release"},{"key":"2776_CR24","doi-asserted-by":"crossref","unstructured":"Soprano E et al. Biomimetic cell-derived nanocarriers in cancer research. J Nanobiotechnol, 2022. 20(1).","DOI":"10.1186\/s12951-022-01748-4"},{"issue":"2","key":"2776_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","volume":"28","author":"SC Semple","year":"2010","unstructured":"Semple SC, et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol. 2010;28(2):172\u2013U18.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"2776_CR26","doi-asserted-by":"publisher","first-page":"18936","DOI":"10.1021\/acsnano.2c07822","volume":"16","author":"ZY Li","year":"2022","unstructured":"Li ZY, et al. Enzyme-catalyzed one-step synthesis of Ionizable Cationic lipids for lipid nanoparticle-based mRNA COVID-19 vaccines. ACS Nano. 2022;16(11):18936\u201350.","journal-title":"ACS Nano"},{"key":"2776_CR27","doi-asserted-by":"crossref","unstructured":"Li Y, Zhao L, Li XF. Targeting Hypoxia: Hypoxia-activated Prodrugs in Cancer Therapy. Front Oncol, 2021. 11.","DOI":"10.3389\/fonc.2021.700407"},{"issue":"1","key":"2776_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL. Hypoxia - A key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38\u201347.","journal-title":"Nat Rev Cancer"},{"key":"2776_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2147\/IJN.S125286","volume":"12","author":"HM Liu","year":"2017","unstructured":"Liu HM, et al. Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy. Int J Nanomed. 2017;12:1065\u201383.","journal-title":"Int J Nanomed"},{"key":"2776_CR30","doi-asserted-by":"crossref","unstructured":"Parrasia S et al. An Angiopep2-PAPTP construct overcomes the blood-brain barrier. New perspectives against Brain tumors. Pharmaceuticals, 2021. 14(2).","DOI":"10.3390\/ph14020129"},{"issue":"12","key":"2776_CR31","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-19-3258","volume":"26","author":"P Kumthekar","year":"2020","unstructured":"Kumthekar P, et al. ANG1005, a brain-penetrating peptide-drug Conjugate, shows activity in patients with breast Cancer with Leptomeningeal Carcinomatosis and recurrent brain metastases. Clin Cancer Res. 2020;26(12):2789\u201399.","journal-title":"Clin Cancer Res"},{"key":"2776_CR32","doi-asserted-by":"crossref","unstructured":"Ruan HT et al. Stapled RAP12 peptide ligand of LRP1 for micelles-based multifunctional glioma-targeted drug delivery. Chem Eng J, 2021. 403.","DOI":"10.1016\/j.cej.2020.126296"},{"key":"2776_CR33","doi-asserted-by":"crossref","unstructured":"Wang K et al. siRNA nanoparticle suppresses drug-resistant gene and prolongs survival in an Orthotopic Glioblastoma Xenograft Mouse Model. Adv Funct Mater, 2021. 31(6).","DOI":"10.1002\/adfm.202007166"},{"issue":"10","key":"2776_CR34","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1158\/1078-0432.CCR-09-1800","volume":"16","author":"B Campos","year":"2010","unstructured":"Campos B, et al. Differentiation therapy exerts Antitumor effects on stem-like glioma cells. Clin Cancer Res. 2010;16(10):2715\u201328.","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2776_CR35","doi-asserted-by":"publisher","first-page":"6870","DOI":"10.1158\/0008-5472.CAN-10-1378","volume":"70","author":"CA Gilbert","year":"2010","unstructured":"Gilbert CA, et al. \u03b3-Secretase inhibitors enhance Temozolomide Treatment of Human gliomas by inhibiting Neurosphere Repopulation and Xenograft Recurrence. Cancer Res. 2010;70(17):6870\u20139.","journal-title":"Cancer Res"},{"key":"2776_CR36","doi-asserted-by":"crossref","unstructured":"Linder B et al. Arsenic Trioxide and (-)-Gossypol synergistically Target Glioma Stem-Like cells via inhibition of hedgehog and Notch Signaling. Cancers, 2019. 11(3).","DOI":"10.3390\/cancers11030350"},{"issue":"1\u20132","key":"2776_CR37","first-page":"70","volume":"347","author":"YF Hu","year":"2009","unstructured":"Hu YF, Smyth GK. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347(1\u20132):70\u20138.","journal-title":"J Immunol Methods"},{"key":"2776_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.addr.2016.06.018","volume":"107","author":"B Tyler","year":"2016","unstructured":"Tyler B, et al. Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Adv Drug Deliv Rev. 2016;107:163\u201375.","journal-title":"Adv Drug Deliv Rev"},{"issue":"47","key":"2776_CR39","doi-asserted-by":"publisher","first-page":"52319","DOI":"10.1021\/acsami.0c12971","volume":"12","author":"HY Xu","year":"2020","unstructured":"Xu HY, et al. Hypoxia-responsive lipid-polymer nanoparticle-combined imaging-guided surgery and multitherapy strategies for Glioma. ACS Appl Mater Interfaces. 2020;12(47):52319\u201328.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"2776_CR40","doi-asserted-by":"publisher","first-page":"10471","DOI":"10.1021\/acsnano.6b06411","volume":"10","author":"F Bertoli","year":"2016","unstructured":"Bertoli F, et al. The intracellular destiny of the protein Corona: a study on its Cellular internalization and evolution. ACS Nano. 2016;10(11):10471\u20139.","journal-title":"ACS Nano"},{"issue":"12","key":"2776_CR41","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden Y, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26(12):1300\u20135.","journal-title":"Genes Dev"},{"key":"2776_CR42","doi-asserted-by":"crossref","unstructured":"Driskill JH, Pan DJ. Control of stem cell renewal and fate by YAP and TAZ. Nature Reviews Molecular Cell Biology; 2023.","DOI":"10.1038\/s41580-023-00644-5"},{"issue":"7","key":"2776_CR43","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41418-023-01166-5","volume":"30","author":"YX Xiong","year":"2023","unstructured":"Xiong YX, et al. Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression. Cell Death Differ. 2023;30(7):1648\u201365.","journal-title":"Cell Death Differ"},{"key":"2776_CR44","doi-asserted-by":"crossref","unstructured":"Li YF et al. Dual pH\/ROS-Responsive nanoplatform with deep tumor penetration and self-amplified drug release for enhancing Tumor Chemotherapeutic Efficacy. Small, 2020. 16(32).","DOI":"10.1002\/smll.202002188"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02776-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:10:01Z","timestamp":1757106601000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02776-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2776"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02776-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article has been revised.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Xuzhou Medical University of China Animal Care and Use Committee (Ethics identifier: 202205A378).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"495"}}